HLX07: Clinical Trials

1 trial of HLX07, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow HLX07: new trials by email Literature Review of HLX07 trials Research Report on HLX07

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer
HLX07, HLX07 placebo, Serplulimab - Squamous NSCLC
Phase 2 / Phase 3Not yet recruitingShanghai Henlius Biotech7202026-03-012026-01-06

Sponsors

Shanghai Henlius Biotech (1)

Countries

China (1)